These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23954887)

  • 41. Motor timing intraindividual variability in amnestic mild cognitive impairment and cognitively intact elders at genetic risk for Alzheimer's disease.
    Kay CD; Seidenberg M; Durgerian S; Nielson KA; Smith JC; Woodard JL; Rao SM
    J Clin Exp Neuropsychol; 2017 Nov; 39(9):866-875. PubMed ID: 28052734
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Latent Cognitive Profiles Differ Between Incipient Alzheimer's Disease and Dementia with Subcortical Vascular Lesions in a Memory Clinic Population.
    Göthlin M; Eckerström M; Lindwall M; Rolstad S; Eckerström C; Jonsson M; Kettunen P; Svensson J; Wallin A
    J Alzheimers Dis; 2020; 73(3):955-966. PubMed ID: 31868665
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association between DCHS2 gene and mild cognitive impairment and Alzheimer's disease in an elderly Brazilian sample.
    Vieira RN; Ávila R; de Paula JJ; Cintra MT; de Souza RP; Nicolato R; Malloy-Diniz L; de Miranda DM; de Moraes EN; de Marco LA; Romano-Silva MA; Bicalho MA
    Int J Geriatr Psychiatry; 2016 Dec; 31(12):1337-1344. PubMed ID: 26876984
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relationship between the Presence of the
    Gutiérrez-de Pablo V; Gómez C; Poza J; Maturana-Candelas A; Martins S; Gomes I; Lopes AM; Pinto N; Hornero R
    Sensors (Basel); 2020 Jul; 20(14):. PubMed ID: 32664228
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
    Löwe LC; Gaser C; Franke K;
    PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cognitive phenotypes in Alzheimer's disease and genetic risk.
    Snowden JS; Stopford CL; Julien CL; Thompson JC; Davidson Y; Gibbons L; Pritchard A; Lendon CL; Richardson AM; Varma A; Neary D; Mann D
    Cortex; 2007 Oct; 43(7):835-45. PubMed ID: 17941342
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lack of reliable evidence for a distinctive ε4-related cognitive phenotype that is independent from clinical diagnostic status: findings from the Australian Imaging, Biomarkers and Lifestyle Study.
    Foster JK; Albrecht MA; Savage G; Lautenschlager NT; Ellis KA; Maruff P; Szoeke C; Taddei K; Martins R; Masters CL; Ames D;
    Brain; 2013 Jul; 136(Pt 7):2201-16. PubMed ID: 23737466
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Severity-Related Increase and Cognitive Correlates of Serum VEGF Levels in Alzheimer's Disease ApoE4 Carriers.
    Alvarez XA; Alvarez I; Aleixandre M; Linares C; Muresanu D; Winter S; Moessler H
    J Alzheimers Dis; 2018; 63(3):1003-1013. PubMed ID: 29710700
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The COMT Val158 Met polymorphism as an associated risk factor for Alzheimer disease and mild cognitive impairment in APOE 4 carriers.
    Martínez MF; Martín XE; Alcelay LG; Flores JC; Valiente JM; Juanbeltz BI; Beldarraín MA; López JM; Gonzalez-Fernández MC; Salazar AM; Gandarias RB; Borda SI; Marqués NO; Amillano MB; Zabaleta MC; de Pancorbo MM
    BMC Neurosci; 2009 Sep; 10():125. PubMed ID: 19793392
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Social Cognition Tests Can Discriminate Behavioral Variant Frontotemporal Dementia From Alzheimer's Disease Independently of Executive Functioning.
    Moura MVB; Mariano LI; Teixeira AL; Caramelli P; de Souza LC
    Arch Clin Neuropsychol; 2021 Jul; 36(5):831-837. PubMed ID: 33034347
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The association between APOE genotype and memory dysfunction in subjects with mild cognitive impairment is related to age and Alzheimer pathology.
    Ramakers IH; Visser PJ; Aalten P; Bekers O; Sleegers K; van Broeckhoven CL; Jolles J; Verhey FR
    Dement Geriatr Cogn Disord; 2008; 26(2):101-8. PubMed ID: 18617739
    [TBL] [Abstract][Full Text] [Related]  

  • 53. APOE genotype and cholesterol levels in lewy body dementia and Alzheimer disease: investigating genotype-phenotype effect on disease risk.
    Borroni B; Grassi M; Costanzi C; Archetti S; Caimi L; Padovani A
    Am J Geriatr Psychiatry; 2006 Dec; 14(12):1022-31. PubMed ID: 16956959
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.
    Monsell SE; Kukull WA; Roher AE; Maarouf CL; Serrano G; Beach TG; Caselli RJ; Montine TJ; Reiman EM
    JAMA Neurol; 2015 Oct; 72(10):1124-31. PubMed ID: 26302353
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of odor identification among amnestic and non-amnestic mild cognitive impairment, subjective cognitive decline, and early Alzheimer's dementia.
    Park SJ; Lee JE; Lee KS; Kim JS
    Neurol Sci; 2018 Mar; 39(3):557-564. PubMed ID: 29383614
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pattern and progression of cognitive decline in Alzheimer's disease: role of premorbid intelligence and ApoE genotype.
    Bracco L; Piccini C; Baccini M; Bessi V; Biancucci F; Nacmias B; Bagnoli S; Sorbi S
    Dement Geriatr Cogn Disord; 2007; 24(6):483-91. PubMed ID: 18025782
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.
    Lane R; Feldman HH; Meyer J; He Y; Ferris SH; Nordberg A; Darreh-Shori T; Soininen H; Pirttilä T; Farlow MR; Sfikas N; Ballard C; Greig NH
    Pharmacogenet Genomics; 2008 Apr; 18(4):289-98. PubMed ID: 18334913
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects.
    Engelborghs S; Dermaut B; Goeman J; Saerens J; Mariën P; Pickut BA; Van den Broeck M; Serneels S; Cruts M; Van Broeckhoven C; De Deyn PP
    J Neurol Neurosurg Psychiatry; 2003 Aug; 74(8):1148-51. PubMed ID: 12876259
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neuropathologic, genetic, and longitudinal cognitive profiles in primary age-related tauopathy (PART) and Alzheimer's disease.
    Bell WR; An Y; Kageyama Y; English C; Rudow GL; Pletnikova O; Thambisetty M; O'Brien R; Moghekar AR; Albert MS; Rabins PV; Resnick SM; Troncoso JC
    Alzheimers Dement; 2019 Jan; 15(1):8-16. PubMed ID: 30465754
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
    Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
    Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.